Todorovic, Z.; Todorovic, D.; Markovic, V.; Ladjevac, N.; Zdravkovic, N.; Djurdjevic, P.; Arsenijevic, N.; Milovanovic, M.; Arsenijevic, A.; Milovanovic, J.
CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings. Curr. Oncol. 2022, 29, 3647-3657.
https://doi.org/10.3390/curroncol29050293
AMA Style
Todorovic Z, Todorovic D, Markovic V, Ladjevac N, Zdravkovic N, Djurdjevic P, Arsenijevic N, Milovanovic M, Arsenijevic A, Milovanovic J.
CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings. Current Oncology. 2022; 29(5):3647-3657.
https://doi.org/10.3390/curroncol29050293
Chicago/Turabian Style
Todorovic, Zeljko, Dusan Todorovic, Vladimir Markovic, Nevena Ladjevac, Natasa Zdravkovic, Predrag Djurdjevic, Nebojsa Arsenijevic, Marija Milovanovic, Aleksandar Arsenijevic, and Jelena Milovanovic.
2022. "CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings" Current Oncology 29, no. 5: 3647-3657.
https://doi.org/10.3390/curroncol29050293
APA Style
Todorovic, Z., Todorovic, D., Markovic, V., Ladjevac, N., Zdravkovic, N., Djurdjevic, P., Arsenijevic, N., Milovanovic, M., Arsenijevic, A., & Milovanovic, J.
(2022). CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings. Current Oncology, 29(5), 3647-3657.
https://doi.org/10.3390/curroncol29050293
